Radiation therapy with chemotherapy for patients with cervical cancer and supraciavicular lymph node involvement
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Seok Ho | - |
dc.contributor.author | Lee, Seung Heon | - |
dc.contributor.author | Lee, Kyu Chan | - |
dc.contributor.author | Lee, Kwang Beonn | - |
dc.contributor.author | Shin, Jin Woo | - |
dc.contributor.author | Park, Chan Yong | - |
dc.contributor.author | Sym, Sun Jin | - |
dc.contributor.author | Lee, Jun-Ho | - |
dc.date.available | 2020-02-29T05:46:25Z | - |
dc.date.created | 2020-02-06 | - |
dc.date.issued | 2012-07 | - |
dc.identifier.issn | 2005-0380 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/16296 | - |
dc.description.abstract | Objective: We wanted to evaluate the outcomes of cervical cancer patients with supraclavicular lymph node (SCLN) involvement and who received radiation therapy (RT) combined with chemotherapy. Methods: From August 2001 to April 2009, nine cervical cancer patients with SCLN involvement were treated by RI and cisplatin-based chemotherapy. Most of the patients (8/9, 88.9%) also had a positive para-aortic lymph node (PALN). The RI field was designed to include the whole pelvis, the involved PALNs and the SCLN area. The median SCLN RI dose was 66.6 Gy (range, 60 to 70 Gy). Results: The median follow-up period was 61 months (range, 13 to 98 months). The 3- and 5-year overall survival rates were 66.7% and 55.6%, respectively and the 3- and 5-year progression-free survival rates were 66.7% and 44.4%, respectively. The acute hematologic toxicities according to the criteria of Radiation Therapy of Oncology Group (RTOG) were G1/2 leucopenia in 3 (33.3%), G3/4 leukopenia in 6 (66.7%), G1/2 anemia in 7 (77.8%), G3 anemia in 1 (11.1%), G2 thrombocytopenia in 2 (22.2%), and G3/4 thrombocytopenia in 2 (22.2%). Within 6 months after RI, most of the patients (5/6, 83.3%) recovered from the G3/4 leukopenia, except for 1 patient who received chemotherapy after completing RI due to subsequent bone metastasis. Conclusion: For patients with advanced cervix cancer and SCLN involvement, RT with chemotherapy as active therapy can be expected to provide favorable results, although there is an increased risk of G3/4 hematologic toxicity. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | KOREAN SOC GYNECOLOGY ONCOLOGY & COLPOSCOPY | - |
dc.relation.isPartOf | JOURNAL OF GYNECOLOGIC ONCOLOGY | - |
dc.title | Radiation therapy with chemotherapy for patients with cervical cancer and supraciavicular lymph node involvement | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000306049500005 | - |
dc.identifier.doi | 10.3802/jgo.2012.23.3.159 | - |
dc.identifier.bibliographicCitation | JOURNAL OF GYNECOLOGIC ONCOLOGY, v.23, no.3, pp.159 - 167 | - |
dc.identifier.kciid | ART001681461 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.scopusid | 2-s2.0-84863556278 | - |
dc.citation.endPage | 167 | - |
dc.citation.startPage | 159 | - |
dc.citation.title | JOURNAL OF GYNECOLOGIC ONCOLOGY | - |
dc.citation.volume | 23 | - |
dc.citation.number | 3 | - |
dc.contributor.affiliatedAuthor | Lee, Seok Ho | - |
dc.contributor.affiliatedAuthor | Lee, Seung Heon | - |
dc.contributor.affiliatedAuthor | Lee, Kyu Chan | - |
dc.contributor.affiliatedAuthor | Lee, Kwang Beonn | - |
dc.contributor.affiliatedAuthor | Shin, Jin Woo | - |
dc.contributor.affiliatedAuthor | Park, Chan Yong | - |
dc.contributor.affiliatedAuthor | Sym, Sun Jin | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | Cervical cancer | - |
dc.subject.keywordAuthor | Chemotherapy | - |
dc.subject.keywordAuthor | Radiation therapy | - |
dc.subject.keywordAuthor | Supraclavicular lymph node | - |
dc.subject.keywordPlus | DOSE-RATE BRACHYTHERAPY | - |
dc.subject.keywordPlus | UTERINE CERVIX | - |
dc.subject.keywordPlus | CONCURRENT CHEMOTHERAPY | - |
dc.subject.keywordPlus | PARAAORTIC IRRADIATION | - |
dc.subject.keywordPlus | CARCINOMA | - |
dc.subject.keywordPlus | RADIOTHERAPY | - |
dc.subject.keywordPlus | METASTASIS | - |
dc.subject.keywordPlus | EXPERIENCE | - |
dc.subject.keywordPlus | BIOPSY | - |
dc.subject.keywordPlus | RISK | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalResearchArea | Obstetrics & Gynecology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.relation.journalWebOfScienceCategory | Obstetrics & Gynecology | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.